These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 21903199)

  • 41. Initiation of β-blocker therapy and depression after acute myocardial infarction.
    Ranchord AM; Spertus JA; Buchanan DM; Gosch KL; Chan PS
    Am Heart J; 2016 Apr; 174():37-42. PubMed ID: 26995368
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proenkephalin and prognosis after acute myocardial infarction.
    Ng LL; Sandhu JK; Narayan H; Quinn PA; Squire IB; Davies JE; Bergmann A; Maisel A; Jones DJ
    J Am Coll Cardiol; 2014 Jan; 63(3):280-9. PubMed ID: 24140658
    [TBL] [Abstract][Full Text] [Related]  

  • 43. N-terminal pro-brain natriuretic peptide is a biomarker of congestive heart failure and predictive of 30-day untoward clinical outcomes in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Wu CJ; Chang HW; Hung WC; Yang CH; Chen YH; Su CY; Yip HK
    Circ J; 2006 Feb; 70(2):163-8. PubMed ID: 16434809
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Limited utilities of N-terminal pro B-type natriuretic peptide and other newer risk markers compared with traditional risk factors for prediction of significant angiographic lesions in stable coronary artery disease.
    Peer A; Falkensammer G; Alber H; Kroiss A; Griesmacher A; Ulmer H; Pachinger O; Mair J
    Heart; 2009 Feb; 95(4):297-303. PubMed ID: 18708421
    [TBL] [Abstract][Full Text] [Related]  

  • 45. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy.
    James SK; Lindahl B; Siegbahn A; Stridsberg M; Venge P; Armstrong P; Barnathan ES; Califf R; Topol EJ; Simoons ML; Wallentin L
    Circulation; 2003 Jul; 108(3):275-81. PubMed ID: 12847065
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inflammation and disease activity are associated with high circulating cardiac markers in rheumatoid arthritis independently of traditional cardiovascular risk factors.
    Avouac J; Meune C; Chenevier-Gobeaux C; Dieudé P; Borderie D; Lefevre G; Kahan A; Allanore Y
    J Rheumatol; 2014 Feb; 41(2):248-55. PubMed ID: 24334650
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sex Differences in Inflammatory Markers and Health Status Among Young Adults With Acute Myocardial Infarction: Results From the VIRGO (Variation in Recovery: Role of Gender on Outcomes of Young Acute Myocardial Infarction Patients) Study.
    Lu Y; Zhou S; Dreyer RP; Spatz ES; Geda M; Lorenze NP; D'Onofrio G; Lichtman JH; Spertus JA; Ridker PM; Krumholz HM
    Circ Cardiovasc Qual Outcomes; 2017 Feb; 10(2):e003470. PubMed ID: 28228461
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Premorbid levels of high-sensitivity cardiac troponin T and natriuretic peptide and prognosis after incident myocardial infarction.
    Mok Y; Sang Y; Ballew SH; Hoogeveen RC; Ballantyne CM; Rosamond W; Coresh J; Selvin E; Matsushita K
    Am Heart J; 2019 Oct; 216():62-73. PubMed ID: 31404723
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Statin has more protective effects in AMI patients with higher plasma BNP or NT-proBNP level, but not with lower left ventricular ejection fraction.
    Cho J; Park IB; Lee K; Ahn TH; Park WB; Kim JH; Ahn Y; Jeong MH; Lee DH;
    J Cardiol; 2018 Apr; 71(4):375-381. PubMed ID: 29158023
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multibiomarker analysis in patients with acute myocardial infarction.
    Schernthaner C; Lichtenauer M; Wernly B; Paar V; Pistulli R; Rohm I; Jung C; Figulla HR; Yilmaz A; Cadamuro J; Haschke-Becher E; Pernow J; Schulze PC; Hoppe UC; Kretzschmar D
    Eur J Clin Invest; 2017 Sep; 47(9):638-648. PubMed ID: 28683166
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High-Sensitive Troponin T, Natriuretic Peptide, and Cognitive Change.
    Pokharel Y; Mouhanna F; Schneider ALC; Rawlings AM; Knopman DS; Nambi V; Virani SS; Hoogeveen RC; Alonso A; Heiss G; Coresh J; Mosley T; Gottesman R; Selvin E; Ballantyne C; Power MC
    J Am Geriatr Soc; 2019 Nov; 67(11):2353-2361. PubMed ID: 31359423
    [TBL] [Abstract][Full Text] [Related]  

  • 53. N-terminal pro-brain natriuretic peptide and the timing, extent and mortality in ST elevation myocardial infarction.
    Ezekowitz JA; Théroux P; Chang W; Mahaffey KW; Granger CB; Weaver WD; Hochman JS; Armstrong PW
    Can J Cardiol; 2006 Apr; 22(5):393-7. PubMed ID: 16639474
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Examining the relation between post myocardial infarction depression and cardiovascular prognosis using a validated prediction model for post myocardial mortality.
    Meurs M; Zuidersma M; Dickens C; de Jonge P
    Int J Cardiol; 2013 Sep; 167(6):2533-8. PubMed ID: 22748495
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
    Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
    Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A multi-marker approach for the prediction of adverse events in patients with acute coronary syndromes.
    Cameron SJ; Sokoll LJ; Laterza OF; Shah S; Green GB
    Clin Chim Acta; 2007 Feb; 376(1-2):168-73. PubMed ID: 17011538
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictive value of depressive symptoms and B-type natriuretic peptide for new-onset heart failure and mortality.
    van den Broek KC; Defilippi CR; Christenson RH; Seliger SL; Gottdiener JS; Kop WJ
    Am J Cardiol; 2011 Mar; 107(5):723-9. PubMed ID: 21316507
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Symptom dimensions of depression following myocardial infarction and their relationship with somatic health status and cardiovascular prognosis.
    de Jonge P; Ormel J; van den Brink RH; van Melle JP; Spijkerman TA; Kuijper A; van Veldhuisen DJ; van den Berg MP; Honig A; Crijns HJ; Schene AH
    Am J Psychiatry; 2006 Jan; 163(1):138-44. PubMed ID: 16390901
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction.
    Latini R; Maggioni AP; Peri G; Gonzini L; Lucci D; Mocarelli P; Vago L; Pasqualini F; Signorini S; Soldateschi D; Tarli L; Schweiger C; Fresco C; Cecere R; Tognoni G; Mantovani A;
    Circulation; 2004 Oct; 110(16):2349-54. PubMed ID: 15477419
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Head-to-Head Comparison of the Incremental Predictive Value of The Three Established Risk Markers, Hs-troponin I, C-Reactive Protein, and NT-proBNP, in Coronary Artery Disease.
    Nikorowitsch J; Ojeda F; Lackner KJ; Schnabel RB; Blankenberg S; Zeller T; Karakas M
    Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32143410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.